Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma
对于新诊断的年轻套细胞淋巴瘤患者,连续R-DA-EDOCH方案与高剂量Ara-C方案交替使用可诱导深度缓解并克服高危因素。
期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2024.0200
Wang, Yi; Yan, Yuting; Shan, Dandan; Chen, Jiawen; Liu, Wei; Wang, Tingyu; An, Gang; Sui, Weiwei; Huang, Wenyang; Xiong, Wenjie; Liu, Huimin; Sun, Qi; Wang, Huijun; Xiao, Zhijian; Wang, Jianxiang; Qiu, Lugui; Zou, Dehui; Yi, Shuhua